This Week in Cardiology cover image

June 16 This Week in Cardiology

This Week in Cardiology

00:00

The Effects of SODA Glyphlosin on Heart Failure

The trial was ended early due to a loss of funding. The PEP, primary efficacy endpoint, SODA Glyphlosin 5.6 versus placebo 7.5 per 100 patient years. Conference intervals were tight at 0.63 to 0.88. Cardiovascular death was not different. Heart failure hospitalization and heart failure visits is what drove the endpoint.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app